HKUOC

藥物資訊-Trodelvy獲批用於轉移性三陰性乳腺癌的二線治療

Trodelvy is approved for the second-line treatment of metastatic triple-negative breast cancer

Leave a Comment / breast cancer, Breast cancer drugs, Chemotherapy, Laboratory examination, Targeted therapy, Pathological diagnosis, Cancer treatment, Types of cancer, Cancer diagnosis, Drug information /

三陰性乳腺癌是一種高度侵襲且目前難以治療的疾病，約占全球所有乳腺癌類型的 15%。在亞洲，乳腺癌的确診年齡中位 […]

Trodelvy is approved for the second-line treatment of metastatic triple-negative breast cancer Read More »

藥物資訊-Enhertu已經獲得美國FDA優先審查資格

Enhertu has obtained the US FDA priority review qualification

Leave a Comment / HER2 gene, EGFR gene, breast cancer, Prostate cancer drugs, Chemotherapy, ovarian cancer, Gene classification articles, colorectal cancer, cervical cancer, Uterine body cancer, Targeted therapy, lymphoma, Cancer treatment, Types of cancer, liver cancer, Lung cancer, Lung cancer drugs, stomach cancer, pancreatic cancer, kidney cancer, brain cancer, Bowel cancer, Drug information, Melanoma, nasopharyngeal cancer /

Enhertu（DS-8201）用於治療HER2突變的不可切除或轉移性非小細胞肺癌經治患者，這一适應症已獲得美

Enhertu has obtained the US FDA priority review qualification Read More »

藥物資訊-膽管癌精準治療藥物Pemigatinib爲患者創造價值

Precision treatment drug Pemigatinib for bile duct cancer creates value for patients

Leave a Comment / Bile duct cancer drugs, FGFR gene, Endoscopic examination, Chemotherapy, Laboratory examination, Gene classification articles, Targeted therapy, Pathological diagnosis, Cancer treatment, Types of cancer, Cancer diagnosis, Bile duct cancer, Drug information /

膽管癌（Cholangiocarcinoma，CCA）是一種罕見（大多數國家發病率低於6/100,000）但致

Precision treatment drug Pemigatinib for bile duct cancer creates value for patients Read More »

藥物資訊-三陰性乳腺癌抗體偶聯藥Trodelvy最新數據

Latest data on Trodelvy, an antibody-coupled drug for triple-negative breast cancer

Leave a Comment / Breast cancer drugs, breast cancer, Chemotherapy, Laboratory examination, Targeted therapy, Pathological diagnosis, Cancer treatment, Types of cancer, Cancer diagnosis, Drug information /

三陰性乳腺癌（TNBC）是一種侵襲性乳腺癌，約占所有乳腺癌的15％。該疾病在年輕和絕經前女性中的更常見。三陰性

Latest data on Trodelvy, an antibody-coupled drug for triple-negative breast cancer Read More »

藥物資訊-KRAS G12C突變肺癌的救星!sotorasib(AMG510)攻克最難靶點

A savior for KRAS G12C-mutant lung cancer! Sotorasib (AMG510) conquers the most difficult target.

Leave a Comment / Drug information, KRAS gene, PD-1 gene, PD-L1 gene, Chemotherapy, Gene classification articles, Genetic testing, Targeted therapy, Pathological diagnosis, Cancer treatment, Types of cancer, Cancer diagnosis, Lung cancer, Lung cancer drugs /

KRAS基因突變，被稱爲世界上最難對付的基因突變，最近迎來了巨大突破性進展。2021年5月29日，美國 FDA

A savior for KRAS G12C-mutant lung cancer! Sotorasib (AMG510) conquers the most difficult target. Read More »

藥物資訊-抗癌前沿|RAS野生型結直腸癌，西妥昔單抗+Avelumab可行

Anti-cancer frontier|RAS wild-type colorectal cancer, cetuximab +Avelumab is feasible

Leave a Comment / Drug information, EGFR gene, KRAS gene, Immunotherapy, Laboratory examination, Gene classification articles, Genetic testing, colorectal cancer, Targeted therapy, Pathological diagnosis, Cancer treatment, Types of cancer, Cancer diagnosis, Colorectal cancer drugs, Bowel cancer, Bowel cancer drugs /

一項單臂、多中心、II期臨床試驗CAVE發現，抗EGFR一線治療有效的化療難治性RAS野生型（WT）轉移性結直

Anti-cancer frontier|RAS wild-type colorectal cancer, cetuximab +Avelumab is feasible Read More »